Showing results (11-20 of 41) with videos related to

Sort By:
Pageof 5
Nuclear Medicine and Biology|December 10, 1999
Characterization of radioactive metabolites of 5-HT2A receptor PET ligand [18F]altanserin in human and rodentP Z Tan, R M Baldwin, C H Van Dyck, et al.
Neurobiology of Aging|August 5, 2000
Age-related decline in central serotonin transporter availability with [(123)I]beta-CIT SPECTC H van Dyck, R T Malison, J P Seibyl, et al.
Psychopharmacology|August 1, 1997
The acetylcholine releaser linopirdine increases parietal regional cerebral blood flow in Alzheimer's diseaseC H van Dyck, C H Lin, R Robinson, et al.
Archives of Neurology|November 21, 1998
Absence of an apolipoprotein E epsilon4 allele is associated with increased parietal regional cerebral blood flow asymmetry in Alzheimer diseaseC H van Dyck, J Gelernter, M G MacAvoy, et al.
Current Alzheimer Research|May 20, 2011
Rosiglitazone does not improve cognition or global function when used as adjunctive therapy to AChE inhibitors in mild-to-moderate Alzheimer's disease: two phase 3 studiesC Harrington, S Sawchak, C Chiang, et al.
The American Journal of Psychiatry|June 10, 1998
Increased striatal dopamine transmission in schizophrenia: confirmation in a second cohortA Abi-Dargham, R Gil, J Krystal, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 25, 2000
PET quantification of 5-HT2A receptors in the human brain: a constant infusion paradigm with [18F]altanserinC H van Dyck, P Z Tan, R M Baldwin, et al.
The American Journal of Psychiatry|September 1, 1995
[123I]beta-CIT SPECT imaging of striatal dopamine transporter binding in Tourette's disorderR T Malison, C J McDougle, C H van Dyck, et al.
The Journal of Neuropsychiatry and Clinical Neurosciences|January 1, 1997
Sustained-release methylphenidate for cognitive impairment in HIV-1-infected drug abusers: a pilot studyC H van Dyck, T J McMahon, M I Rosen, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 18, 1997
Test/retest reproducibility of iodine-123-betaCIT SPECT brain measurement of dopamine transporters in Parkinson's patientsJ P Seibyl, K Marek, K Sheff, et al.
Pageof 5